Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

International Nurses Day: a day in the life of Lynn Hundley

International Nurses Day: a day in the life of Ismalia de Sousa

Novartis to seek US approval of siponimod for SPMS: industry news round up

CNS/PNS/SNS

Reprogrammed neuronal stem cells survive long-term in spinal cord injury model

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

New pathways identified in restricting CNS axonal regeneration

Cognitive/neurodegenerative disorders

UK Biobank: new genetic risk factors for Alzheimer’s disease identified

Dementia exercise programs may not slow cognitive decline, study indicates

Multiple sclerosis: new UK guidelines on disease-modifying therapies

Demyelinating disease

Multiple sclerosis: new UK guidelines on disease-modifying therapies

First disease-modifying therapy approved for pediatric multiple sclerosis: industry news round-up

Could hyaluronic acid contribute to chronic white matter injury?

Development and pediatrics

NCTalks with Giovanni Baranello: spinal muscular atrophy and the FIREFISH trial

Possible biomarker for autism identified in cerebrospinal fluid

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

Epilepsy and seizure

Epilepsy and cannabinoids: current consensus, controversies and future outlook

Reports of brain damage call a halt to Bellicum trials: industry news round-up

Could novel epileptic encephalopathy genes promote advances in treatment strategy?

Genetics

UK Biobank: new genetic risk factors for Alzheimer’s disease identified

New pathways identified in restricting CNS axonal regeneration

Novartis to seek US approval of siponimod for SPMS: industry news round up

Headache

Aimovig™ gains US FDA approval for the preventive treatment of migraine

ALKS 5461 accepted for review following previous refusal-to-file for depression: industry news round-up

AAN 2018: Novel therapy for ‘difficult-to-treat’ migraines revealed

Immune disorders and inflammation

Could hyaluronic acid contribute to chronic white matter injury?

Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients

NCTalks at SfN17: Doris Doudet on Parkinson's, inflammation and the gut

Infection

NCTalks at SfN17: Kijun Yoon gives a Zika update

SfN17: CRISPR and iPSCs – new techniques to study the brain

Infographic: The facts about Zika

Injury/trauma

Reprogrammed neuronal stem cells survive long-term in spinal cord injury model

Study indicates all degrees of concussion may increase the risk of Parkinson’s disease

Is there a link between traumatic brain injury and dementia?

Movement disorders

Multiple sclerosis: new UK guidelines on disease-modifying therapies

AAN 2018: Nerve stimulation device may help relieve essential tremors in the hand

Study indicates all degrees of concussion may increase the risk of Parkinson’s disease

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis

Possible biomarker for autism identified in cerebrospinal fluid

ALKS 5461 accepted for review following previous refusal-to-file for depression: industry news round-up

Oncology/tumor

First disease-modifying therapy approved for pediatric multiple sclerosis: industry news round-up

£18 million fund towards brain tumor research launched

Could Huntington’s disease act as an anti-cancer tool?

Pain

Aimovig™ gains US FDA approval for the preventive treatment of migraine

Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition

Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients

Sleep

#NCIntroduces... Sleep science

Better sleep works like a dream at reducing fear learning

Sleep research realizes the dream of understanding brain plasticity mechanisms